Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy
Authors:
- 1 September 2010
- journal article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 143 (3) , 367-374
Abstract
OBJECTIVE: To determine whether computed tomography can distinguish low risk neck levels that can be omitted when neck dissection is undertaken after chemoradiotherapy.STUDY DESIGN: Case series with chart review.SETTING: Tertiary care center.SUBJECTS AND METHODS: Head and neck squamous cell carcinoma patients undergoing neck dissection after chemoradiotherapy between January 1998 and June 2008. We compared computed tomography findings after chemoradiotherapy with neck dissection pathology results; used primary location and computed tomography findings to design selective or superselective neck dissection; and determined whether these surgeries would have contained all metastatic disease.RESULTS: A total of 104 patients were identified, providing 110 heminecks, 531 neck levels, and 3009 lymph nodes for analysis. Neck dissections were positive in 20 (19%) of 104 patients, corresponding to 20 hemineck dissections, 31 neck levels, and 53 lymph nodes. The negative predictive value for computed tomography was 95 percent. The negative predictive value for computed tomography per neck level was as follows: I, 100 percent; II, 96 percent; III, 96 percent; IV, 97 percent; and V, 96 percent. A selective neck dissection or a superselective neck dissection, guided by level specific computed tomography findings and limited to necks with post treatment partial response in one level, would have captured all disease in 52 (95%) of 55 and 51 (93%) of 55 heminecks.CONCLUSION: Negative computed tomography accurately predicts pathologic complete response at neck dissection. Neck dissection can be avoided in these patients. Additionally, computed tomography reliably identifies low risk neck levels that do not require dissection, permitting selective neck dissection or superselective neck dissection in partial response patients with limited residual disease.© 2010 American Academy of Otolaryngology‐Head and Neck Surgery Foundation. All rights reserved.Keywords
This publication has 28 references indexed in Scilit:
- Positron emission tomography–computed tomography surveillance for the node‐positive neck after chemoradiotherapyThe Laryngoscope, 2009
- Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapyHead & Neck, 2009
- Selective neck dissection following adjuvant therapy for advanced head and neck cancerHead & Neck, 2008
- Radiographic Complete Response on Post Treatment CT Imaging Eliminates the Need for Adjuvant Neck Dissection After Treatment for Node Positive Head and Neck CancerAmerican Journal of Clinical Oncology, 2008
- Clinical Utility of18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck CancerJournal of Nuclear Medicine, 2008
- Planned Postradiotherapy Neck Dissection: Rationale and Clinical OutcomesThe Laryngoscope, 2007
- Examining the Need for Neck Dissection in the Era of Chemoradiation Therapy for Advanced Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 2006
- Neck dissection in the combined‐modality therapy of patients with locoregionally advanced head and neck cancerHead & Neck, 2004
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual dataThe Lancet, 2000
- Efficacy of Targeted Chemoradiation and Planned Selective Neck Dissection to Control Bulky Nodal Disease in Advanced Head and Neck CancerJAMA Otolaryngology–Head & Neck Surgery, 1999